“given the upward move in hospitalizations, that (the death rate) won’t be far behind.”
We can hope that the younger population of these new cases will hold up better than the older folks who were more heavily represented in last Winter’s wave.
But the next few weeks will tell.
There is a fear, that just as the mutations in Delta make it marginally more evasive to the immune system and vaccine protection, that the antibody cocktail treatment may also be marginally less effective. I have seen some state that already.
Good point regarding the age demographic. It’s never encouraging to see hospitalizations ticking up, but the relatively younger people’s mortality should be lower.
I can’t help but wonder if the same effect is driving the perceived narrative that the Delta variant is less virulent. Hope not.